Sofinnova Venture Partners X, L.P.

Insider Reports History

Entity
Company
Location
3000 Sand Hill Road, 4 250, Menlo Park, CA
Signature
/s/ Nathalie Auber, as attorney-in-fact for Sofinnova Venture Partners X, L.P.
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sofinnova Venture Partners X, L.P.:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CinCor Pharma, Inc. 10%+ Owner Common Stock 6.07M $175M $28.75 Aug 11, 2022 By Sofinnova Venture Partners X, L.P.
Aerovate Therapeutics, Inc. 10%+ Owner Common Stock 3.76M $73.3M $19.50 Jul 2, 2021 Direct
Vera Therapeutics, Inc. 10%+ Owner Class A Common Stock 3.47M $62.4M $18.00 Feb 6, 2023 Direct
Aerovate Therapeutics, Inc. 10%+ Owner Series A Preferred Stock 0 Jul 2, 2021 Direct

Insider Reports Filed by Sofinnova Venture Partners X, L.P.

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VERA Vera Therapeutics, Inc. Feb 6, 2023 1 $2M 4 Feb 8, 2023 10%+ Owner
CINC CinCor Pharma, Inc. Aug 11, 2022 1 $15M 4 Aug 15, 2022 10%+ Owner
VERA Vera Therapeutics, Inc. Feb 10, 2022 1 $4M 4 Feb 14, 2022 10%+ Owner
CINC CinCor Pharma, Inc. Jan 11, 2022 4 $5.2M 4 Jan 13, 2022 10%+ Owner
CINC CinCor Pharma, Inc. Jan 6, 2022 0 $0 3 Jan 6, 2022 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jul 2, 2021 3 $5M 4 Jul 6, 2021 10%+ Owner
AVTE Aerovate Therapeutics, Inc. Jun 29, 2021 0 $0 3 Jun 29, 2021 10%+ Owner
VERA Vera Therapeutics, Inc. May 18, 2021 3 $8M 4 May 18, 2021 10%+ Owner
VERA Vera Therapeutics, Inc. May 13, 2021 0 $0 3 May 13, 2021 10%+ Owner